Opportunities in the medical biomimetic market have evolved through a number of stages. Lucintel has found the future of this market to be promising; the medical biomimetic market is expected to grow at a CAGR of 5%-7%. In this market, cardiovascular is the largest segment by product, whereas drug delivery is largest by application. Players can benefit from the available ... Read more